Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Sep 21, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 10, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
- Aug 10, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record64613 flagged findings
Reported transactions (Form 4)80since Jan 17, 2023 · and 5 other holdings
Corporate events (8-K)30since Jun 9, 2023
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Identity
Formerly traded as OCX.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-13share offering or dilution eventrecentOpen filing ↗“…warrants have been exercised. 30 Table of Contents INSIGHT MOLECULAR DIAGNOSTICS INC. NOTES TO UNAUDITED CONDENSED CONSOLIDATED…”
- 2026-05-13merger or acquisition eventrecentOpen filing ↗“…consolidated balance sheets and consolidated statements of operations, comprehensive loss, shareholders' (deficit) equity and…”
+1 more passage from the same document
- “…Balance at December 31, 2024 $ 2,593 Change in estimated fair value 31 Balance at March 31, 2025 $ 2,624 Balance at December…”
- 2026-03-26share offering or dilution eventrecentOpen filing ↗“…31, 2023 5 $ 5,126 8,261 $ 310,295 $ 49 $ ( 289,876 ) $ 20,468 Net loss — — — — — ( 60,663 ) ( 60,663 ) Foreign currency translation…”
+1 more passage from the same document
- “…Vesting of bonus awards — — — 52 — — 52 Sale of common shares, net of financing costs — — 8,538 24,638 — — 24,638 Sale of common…”
- 2026-03-26listing compliance noticerecentOpen filing ↗“…we expect that we would take actions to restore our compliance with Nasdaq s listing requirements, but we can provide no…”
+1 more passage from the same document
- “…delisting, we expect that we would take actions to restore our compliance with Nasdaq s listing requirements, but we can provide no…”
- 2026-03-26Department of Justice inquiryrecentOpen filing ↗“…provisions requiring us to maintain books and records that accurately and fairly reflect all transactions of the corporation,…”
- 2026-03-26merger or acquisition eventrecentOpen filing ↗“…deficit and cash flows, and related interim disclosures. F- 23 Table of Contents INSIGHT MOLECULAR DIAGNOSTICS INC. NOTES…”
+1 more passage from the same document
- “…Balance at December 31, 2023 $ 2,040 Change in estimated fair value 553 Balance at December 31, 2024 $ 2,593 Balance at December 31,…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
Reverse splits in 5 years
1 reverse split in 5 years (1:20 on Jul 25, 2023) · 1:20 cumulative
The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 646)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Sep 21, 268-K ↗Current report · Entered a material agreement
- Aug 10, 2610-Q ↗Quarterly report
- Aug 10, 268-K ↗Current report · Results · Communication to the market · Other events
- Jun 17, 268-K ↗Current report · A senior executive left or was appointed
- May 13, 2610-Q ↗Quarterly report
- May 13, 268-K ↗Current report · Results
- May 13, 268-K/A ↗Current report · Other events · amendment
- Apr 30, 26DEFA14A ↗Shareholder meeting and votes
- Apr 30, 26DEF 14A ↗Shareholder meeting and votes
- Apr 30, 268-K ↗Current report · Other events
- Apr 27, 26SCHEDULE 13D/A ↗Stake with intent to influence · Broadwood Partners, L.P. · 39.7% · event on Apr 23, 26 · amendment
- Mar 26, 2610-K ↗Annual report
- Mar 26, 268-K ↗Current report · Results
- Feb 26, 268-K ↗Current report · Entered a material agreement
646 filings on record, the oldest from Nov 5, 15.
Listing the 25 most recent filings of the 646 on record.
96959
- Sep 21, 26Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Jun 17, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Feb 26, 26Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Feb 12, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Oct 2, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Sep 19, 25A senior executive left or was appointed8-K 5.02 ↗
- Apr 17, 25Auditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
- Mar 10, 25A senior executive left or was appointed8-K 5.02 ↗
- Feb 10, 25Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Jan 8, 25Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Oct 15, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Oct 3, 24Entered a material agreement+4 more in the same filing8-K 1.01 ↗
13 older filings not shown · The record reaches back to Jan 12, 16.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Jul 12, 24Listing notice (8-K 3.01)8-K 3.01 ↗
- Apr 13, 23Restructuring plan with committed costs+1 more in the same filing8-K 2.05 ↗
- Feb 13, 23Listing notice (8-K 3.01)+3 more in the same filing8-K 3.01 ↗
- Jan 30, 23Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Dec 21, 22Restructuring plan with committed costs+4 more in the same filing8-K 2.05 ↗
- Aug 15, 22Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Aug 10, 22Restructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
- Feb 25, 21Listing notice (8-K 3.01)+4 more in the same filing8-K 3.01 ↗
- Nov 29, 17Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
The full record holds 9 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Broadwood Partners, L.P.39.7%Apr 23, 26SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Patrick W. Smith10.5%Dec 26, 24SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- AWM Investment Company, Inc.10.0%Mar 31, 25SCHEDULE 13G/A ↗1 earlier filing
- BIO-RAD LABORATORIES, INC9.7%Feb 10, 25SCHEDULE 13G/A ↗
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- Apr 27, 26Buy$913KBROADWOOD PARTNERS, L.P.↗
- Apr 27, 26Buyamount n/aBROADWOOD PARTNERS, L.P.↗
- Apr 24, 26Buy$137KBROADWOOD PARTNERS, L.P.↗
- Apr 24, 26Buyamount n/aBROADWOOD PARTNERS, L.P.↗
- Apr 23, 26Buy$982KBROADWOOD PARTNERS, L.P.↗
- Apr 23, 26Buyamount n/aBROADWOOD PARTNERS, L.P.↗
- Apr 20, 26Buy$158KBROADWOOD PARTNERS, L.P.↗
- Apr 20, 26Buyamount n/aBROADWOOD PARTNERS, L.P.↗
- Apr 17, 26Buy$143KBROADWOOD PARTNERS, L.P.↗
- Apr 17, 26Buyamount n/aBROADWOOD PARTNERS, L.P.↗
- Apr 16, 26Buy$352KBROADWOOD PARTNERS, L.P.↗
- Apr 16, 26Buyamount n/aBROADWOOD PARTNERS, L.P.↗
There are 10 more transactions in this stretch.
Stock compensation, tax and giftsshow the 18 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Jul 1, 26Tax$69KAndrew Arno↗
- Jul 1, 26Tax$44KAndrew J. Last↗
- Jul 1, 26Tax$44KLOU SILVERMAN↗
- Jun 11, 26Compensationamount n/aAndrew Arno↗
- Jun 11, 26Compensationamount n/aAndrew J. Last↗
- Jun 11, 26Compensationamount n/aLOU SILVERMAN↗
- Mar 26, 26Compensationamount n/aJosh RiggsCEO and President↗
- Mar 26, 26Tax$51KJosh RiggsCEO and President↗
- Mar 26, 26Compensationamount n/aJames Yang LiuVP ACCT, Cntlr, Treasurer, PAO↗
- Mar 26, 26Tax$11KJames Yang LiuVP ACCT, Cntlr, Treasurer, PAO↗
- Mar 26, 26Compensationamount n/aAndrea S. JamesChief Financial Officer↗
- Mar 26, 26Tax$46KAndrea S. JamesChief Financial Officer↗
- Oct 31, 25Compensationamount n/aAndrea S. JamesChief Financial Officer↗
- Oct 31, 25Tax$73KAndrea S. JamesChief Financial Officer↗
- Jul 1, 25Compensationamount n/aAndrew J. Last↗
- Jul 1, 25Compensationamount n/aLOU SILVERMAN↗
- Jul 1, 25Compensationamount n/aAndrew Arno↗
- Feb 7, 25Other$791KPATRICK W SMITH↗
The full record holds 69 transactions and goes back to Jan 17, 23.
Its sector and its market
Insight Molecular Diagnostics Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Insight Molecular Diagnostics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Insight Molecular Diagnostics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 646 documents on file, from Nov 5, 2015 to Sep 21, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.